{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:19:06Z","timestamp":1766391546960},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sun Yat-sen Clinical Research Cultivating Program","award":["SYS-Q-201705"],"award-info":[{"award-number":["SYS-Q-201705"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10103-020-03054-7","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T04:02:21Z","timestamp":1592366541000},"page":"147-152","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of a fractional 2940-nm Er:YAG laser and 5% amorolfine lacquer combination therapy versus a 5% amorolfine lacquer monotherapy for the treatment of onychomycosis: a randomized controlled trial"],"prefix":"10.1007","volume":"36","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaiqiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"3054_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","volume":"80","author":"SR Lipner","year":"2019","unstructured":"Lipner SR, Scher RK (2019) Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol 80:853\u2013867","journal-title":"J Am Acad Dermatol"},{"key":"3054_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1203475417716362","volume":"21","author":"AK Gupta","year":"2017","unstructured":"Gupta AK, Versteeg SG, Shear NH (2017) Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg 21:525\u2013539","journal-title":"J Cutan Med Surg"},{"key":"3054_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00105-016-3853-8","volume":"67","author":"A D\u00fcrrbeck","year":"2016","unstructured":"D\u00fcrrbeck A, Nenoff P (2016) Terbinafine : relevant drug interactions and their management. Hautarzt 67:718\u2013723","journal-title":"Hautarzt"},{"key":"3054_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s13555-018-0254-1","volume":"8","author":"F Eertmans","year":"2018","unstructured":"Eertmans F, Doss N, Rossel B, Adriaens E (2018) Daily application of an aqueous, acidifying, peelable nail polish versus weekly amorolfine for topical onychomycosis treatment: a prospective, randomized, blinded trial. Dermatol Ther (Heidelb) 8:463\u2013473","journal-title":"Dermatol Ther (Heidelb)"},{"key":"3054_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2133.2009.09504.x","volume":"162","author":"D Monti","year":"2010","unstructured":"Monti D, Saccomani L, Chetoni P, Burgalassi S, Senesi S, Ghelardi E et al (2010) Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity. Br J Dermatol 162:311\u2013317","journal-title":"Br J Dermatol"},{"key":"3054_CR6","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s10103-019-02789-2","volume":"34","author":"RA El-Tatawy","year":"2019","unstructured":"El-Tatawy RA, Aliweh HA, Hegab DS, RAZ T, Shams EMA (2019) Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. Lasers Med Sci 34:1873\u20131880","journal-title":"Lasers Med Sci"},{"key":"3054_CR7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s10103-016-1990-z","volume":"31","author":"J Zhang","year":"2016","unstructured":"Zhang J, Lu S, Huang H, Li X, Cai W, Ma J et al (2016) Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer. Lasers Med Sci 31:1391\u20131396","journal-title":"Lasers Med Sci"},{"key":"3054_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/archdermatol.2011.267","volume":"147","author":"C Carney","year":"2011","unstructured":"Carney C, Tosti A, Daniel R, Scher R, Rich P, DeCoster J et al (2011) A new classification system for grading the severity of onychomycosis: onychomycosis severity index. Arch Dermatol 147:1277\u20131282","journal-title":"Arch Dermatol"},{"key":"3054_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jaad.2014.01.893","volume":"70","author":"EH Lim","year":"2014","unstructured":"Lim EH, Kim HR, Park YO, Lee Y, Seo YJ, Kim CD et al (2014) Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. J Am Acad Dermatol 70:918\u2013923","journal-title":"J Am Acad Dermatol"},{"key":"3054_CR10","doi-asserted-by":"publisher","first-page":"e5141","DOI":"10.1097\/MD.0000000000005141","volume":"95","author":"BR Zhou","year":"2016","unstructured":"Zhou BR, Lu Y, Permatasari F, Huang H, Li J, Liu J et al (2016) The efficacy of fractional carbon dioxide (CO2) laser combined with luliconazole 1% cream for the treatment of onychomycosis: a randomized, controlled trial. Medicine (Baltimore) 95:e5141 controlled trial. Medicine (Baltimore) 95:e5141","journal-title":"Medicine (Baltimore)"},{"key":"3054_CR11","first-page":"143","volume":"13","author":"D Monti","year":"2014","unstructured":"Monti D, Tampucci S, Chetoni P, Burgalassi S, Mailland F (2014) Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers. J Drugs Dermatol 13:143\u2013147","journal-title":"J Drugs Dermatol"},{"key":"3054_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejpb.2016.03.008","volume":"102","author":"WJ McAuley","year":"2016","unstructured":"McAuley WJ, Jones SA, Traynor MJ, Guesn\u00e9 S, Murdan S, Brown MB (2016) An investigation of how fungal infection influences drug penetration through onychomycosis patient\u2019s nail plates. Eur J Pharm Biopharm 102:178\u2013184","journal-title":"Eur J Pharm Biopharm"},{"key":"3054_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/0974-2077.155068","volume":"8","author":"K Sardana","year":"2015","unstructured":"Sardana K, Ghunawat S (2015) Lasers for Lentigines, from Q-switched to erbium-doped yttrium aluminium garnet micropeel, is there a need to reinvent the wheel. J Cutan Aesthet Surg 8:233\u2013235","journal-title":"J Cutan Aesthet Surg"},{"issue":"Suppl 1","key":"3054_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1365-2230.1992.tb00273.x","volume":"17","author":"F Pittrof","year":"1992","unstructured":"Pittrof F, Gerhards J, Erni W, Klecak G (1992) Loceryl nail lacquer--realization of a new galenical approach to onychomycosis therapy. Clin Exp Dermatol 17(Suppl 1):26\u201328","journal-title":"Clin Exp Dermatol"},{"key":"3054_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0378-5173(00)00427-0","volume":"202","author":"A L\u00f3pez","year":"2000","unstructured":"L\u00f3pez A, Llinares F, Cortell C, Herr\u00e1ez M (2000) Comparative enhancer effects of Span20 with Tween20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm 202:133\u2013140","journal-title":"Int J Pharm"},{"key":"3054_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1211\/0022357991772448","volume":"51","author":"Y Kobayashi","year":"1999","unstructured":"Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y (1999) Drug permeation through the three layers of the human nail plate. J Pharm Pharmacol 51:271\u2013278","journal-title":"J Pharm Pharmacol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-020-03054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-020-03054-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-020-03054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:18:22Z","timestamp":1623889102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-020-03054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1007\/s10103-020-03054-7","relation":{},"ISSN":["0268-8921","1435-604X"],"issn-type":[{"value":"0268-8921","type":"print"},{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This funding body did not provide any direction to the current study design; collection, analysis, or interpretation of data; the writing of the manuscript; and the decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Sun Yat-sen Memorial Hospital (ethical number 2017018) and in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The written informed consent approved by the Ethics Committee of Sun Yat-sen Memorial Hospital was obtained for all study participants prior to study participation.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}